Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Frontiers in Oncology|December 11, 2012
p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic SignificanceLindi Chen, Deborah A TweddleCell Cycle (Georgetown, Tex.)|May 15, 2007
Cell cycle regulation targets of MYCN identified by gene expression microarraysEmma Bell, John Lunec, Deborah A TweddleSeminars in Fetal & Neonatal Medicine|June 8, 2012
Neonatal neuroblastomaJonathan P H Fisher, Deborah A TweddleCancers|February 13, 2026
Detection and Characterisation of Circulating Tumour Cell Clusters in NeuroblastomaZoe Bell, Swathi Merugu, David Jamieson, et al.Expert Reviews in Molecular Medicine|June 9, 2020
DNA damage checkpoint kinases in cancerHannah L Smith, Harriet Southgate, Deborah A Tweddle, et al.Cancers|May 2, 2020
ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple MechanismsHarriet E D Southgate, Lindi Chen, Deborah A Tweddle, et al.European Journal of Cancer (Oxford, England : 1990)|March 2, 2019
A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastomaFiona Herd, Nermine O Basta, Richard J Q McNally, et al.Frontiers in Oncology|April 21, 2020
Targeting the DNA Damage Response for the Treatment of High Risk NeuroblastomaHarriet E D Southgate, Lindi Chen, Nicola J Curtin, et al.British Journal of Cancer|October 10, 2023
Generation of evidence-based carboplatin dosing guidelines for neonates and infantsShelby Barnett, Guy Makin, Deborah A Tweddle, et al.Pediatric Blood & Cancer|May 29, 2019
The use of pharmacokinetically guided carboplatin chemotherapy in a pre-term infant with neuroblastoma-associated spinal cord compressionJessica Hawley, Gareth J Veal, Julie Errington, et al.Pageof 7